Yahoo! Finance: OXGN.ST NewsCopyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=oxgn.stLatest Financial News for OXIGENEen-usMon, 7 Dec 2009 14:49:09 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifYahoo! Financehttp://finance.yahoo.com14417OXiGENE Reports Promising Preclinical Data Using OXi4503 in Acute Myelogenous Leukemia Models at ASH Conference (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091207/179796.html?.v=1yahoo_finance/3909162864Mon, 7 Dec 2009 14:49:09 Etc/GMTOXiGENE Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2009 AACR-NCI-EORTC Conference (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091117/178573.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today reported positive interim safety data from the FALCON study, a Phase 2, randomized, controlled study of ZYBRESTAT in patients with advanced non-small cell lung cancer .yahoo_finance/3910149794Tue, 17 Nov 2009 17:30:00 Etc/GMTOXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC Meetings (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091112/178317.html?.v=1yahoo_finance/4111268325Thu, 12 Nov 2009 21:00:00 Etc/GMTOXiGENE to Present at Merriman Curhan Ford and Lazard Healthcare Conferences (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091110/178014.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that OXiGENE Management will present a corporate overview and update at the Merriman Curhan Ford Investor Summit at 12:00 noon EST today at the Sofitel Hotel in New York City, N.Y.yahoo_finance/194580955Tue, 10 Nov 2009 07:00:00 Etc/GMTOXiGENE Reports Third Quarter 2009 Financial Results (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091109/177885.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter and nine months ended September 30, 2009 and presented an update on recent clinical and corporate progress.yahoo_finance/453676018Mon, 9 Nov 2009 07:00:00 Etc/GMTOXiGENE Announces Third Quarter 2009 Earnings Conference Call and Webcast (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091103/177268.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report third quarter 2009 results on Monday, November 9th, 2009.yahoo_finance/3058900329Tue, 3 Nov 2009 07:00:00 Etc/GMTOXiGENE to Acquire VaxGen in a Stock-for-Stock Merger (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091015/175565.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, and VaxGen, Inc. , a biopharmaceutical company, announced today that they have entered into a definitive merger agreement pursuant to which OXiGENE will acquire VaxGen in exchange for common stock of OXiGENE.yahoo_finance/3222944693Thu, 15 Oct 2009 10:00:00 Etc/GMTOXiGENE Announces Data Presentation At 2009 AACR-EORTC-NCI Conference (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091012/175207.html?.v=1yahoo_finance/580428235Mon, 12 Oct 2009 12:00:00 Etc/GMTOxigene Announces Management Changes (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091008/175029.html?.v=1yahoo_finance/1865060310Thu, 8 Oct 2009 12:00:00 Etc/GMTOXiGENE Reports Second Quarter 2009 Financial Results; Company Continues to Achieve Pipeline Progress With Strengthened Cash Position (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090730/170225.html?.v=1yahoo_finance/763772896Thu, 30 Jul 2009 06:00:00 Etc/GMTOXiGENE Announces Second Quarter 2009 Earnings Conference Call and Webcast (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090724/169747.html?.v=1yahoo_finance/1579365246Fri, 24 Jul 2009 06:00:00 Etc/GMTOXiGENE Announces Closing of Registered Direct Offering (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090721/169394.html?.v=1yahoo_finance/426896221Tue, 21 Jul 2009 06:00:00 Etc/GMTOXiGENE to Raise $10 Million in Registered Direct Offering (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090715/169007.html?.v=1yahoo_finance/1089773449Wed, 15 Jul 2009 13:00:00 Etc/GMTOXiGENE Announces Agreement to Acquire Symphony ViDA, Including More Than $12 Million in Unrestricted Cash and All Rights to OXi4503 and ZYBRESTAT for Ophthalmology (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090706/168362.html?.v=1yahoo_finance/225852562Mon, 6 Jul 2009 06:00:00 Etc/GMTOXiGENE Initiates Phase 2 Trial of ZYBRESTAT for Ophthalmology (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090625/167852.html?.v=1yahoo_finance/207154805Thu, 25 Jun 2009 06:00:00 Etc/GMTOXiGENE Appoints Dr. Peter J. Langecker as Chief Development Officer (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090617/167434.html?.v=3yahoo_finance/419443998Wed, 17 Jun 2009 06:00:00 Etc/GMTOXiGENE Reports Positive Data From Phase 2 Trial of ZYBRESTAT in Platinum Resistant Ovarian Cancer At the 2009 ASCO Annual Meeting (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090601/166397.html?.v=3yahoo_finance/9496200Mon, 1 Jun 2009 14:45:00 Etc/GMTOXiGENE Announces Clinical Data to be Presented At the 2009 Annual Meeting of the American Society of Clinical Oncology (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090521/165870.html?.v=4yahoo_finance/165835419Thu, 21 May 2009 06:00:00 Etc/GMTOXiGENE Reports First Quarter 2009 Financial Results (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090511/165141.html?.v=4yahoo_finance/1307717389Mon, 11 May 2009 20:00:00 Etc/GMTOXiGENE Announces First Quarter 2009 Earnings Conference Call and Webcast (GlobeNewswire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090504/164461.html?.v=3yahoo_finance/2957501036Mon, 4 May 2009 06:00:00 Etc/GMT